# Role of 13C Methacetin Breath Test in Predicting Prognosis Among Patients With Acute or Acute on Chronic Liver Failure (ACLF).

> **NCT01946360** · NA · COMPLETED · sponsor: **Institute of Liver and Biliary Sciences, India** · enrollment: 24 (actual)

## Conditions studied

- Acute Liver Failure
- Acute on Chronic Liver Failure

## Interventions

- **DEVICE:** Methacetin Breath Test in ACLF and ALF patients

## Key facts

- **NCT ID:** NCT01946360
- **Lead sponsor:** Institute of Liver and Biliary Sciences, India
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04
- **Primary completion:** 2015-01
- **Final completion:** 2015-01
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2015-09-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01946360

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01946360, "Role of 13C Methacetin Breath Test in Predicting Prognosis Among Patients With Acute or Acute on Chronic Liver Failure (ACLF).". Retrieved via AI Analytics 2026-06-06 from https://api.ai-analytics.org/clinical/NCT01946360. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*